Following the overwhelming response to the Hailey Bieber episode, SHE MD sits down with Sera Prognostics CEO Zhenya Lindgardt and Chief Medical Officer Dr. Tiffany Inglis for a powerful, science-backed conversation about preterm birth, maternal health, and the pregnancy blood test most women, and most doctors, have never heard of. They unpack how a simple test taken between 18 and 20 weeks can predict and help prevent preterm birth in women who would otherwise be considered "low risk."
This conversation goes deep into the science behind the PreTRM test and the two proteins it measures. The doctors explain why other current screening methods miss nearly 80% of women who will go on to deliver prematurely, and how the preTRM® test is changing maternal care from reactive to preventive. They break down the role inflammation and placental health play in pregnancy, and how the preventive protocol used in the PRIME study helped reduce early preterm births by 56%. They also dive into the emotional, physical, and financial toll of NICU stays, disparities in maternal healthcare, and why women need better access to personalized pregnancy care.
This episode is ultimately about agency: knowing your individual risk, advocating for the care you deserve, and shifting maternal medicine from reactive to preventive. Whether you're pregnant, planning to be, or supporting someone who is, this conversation delivers the science, the resources, and the mindset shift that could change the trajectory of a pregnancy and the lives that depend on it.
Learn more here: https://pretrm.com/?utm_source=shemd&utm_medium=podcast&utm_campaign=founders_ep

Zhenya Lindgardt is the CEO of Sera Prognostics, a women’s health biotechnology company focused on improving pregnancy outcomes through predictive diagnostics. Under her leadership, Sera has advanced groundbreaking research in maternal health, including the development of the preTRM® test, a first-of-its-kind blood test designed to identify a woman’s risk for spontaneous preterm birth before symptoms begin. Passionate about preventive and personalized maternal care, Zhenya is committed to expanding access to innovative tools that empower women and improve outcomes for mothers and babies worldwide.

Dr. Tiffany Inglis is the Chief Medical Officer of Sera Prognostics and a board-certified OB-GYN with extensive experience in maternal healthcare, patient education, and pregnancy risk management. Before joining Sera, she worked in clinical practice and healthcare innovation, developing programs focused on improving outcomes for pregnant women through early intervention and personalized care. At Sera, Dr. Inglis helps lead research and education surrounding the preTRM® test and advocates for a more proactive approach to maternal health.
What You’ll Learn
Key Timestamps
0:00 Welcome Zhenya Lindgardt & Dr. Tiffany Inglis
1:05 Why Preterm Birth Can Happen to Anyone
2:51 How They Met and The Story Behind Sera Prognostics
5:39 What Counts as a Preterm Birth?
6:49 The Dangerous Complications of Early Delivery
9:11 How the PreTRM Blood Test Works
13:35 What Happens After a High-Risk Result
15:08 The Science Behind the Proteins
16:16 The PRIME Study Results Explained
18:39 Why Most Doctors Still Don’t Use This Test
20:25 The Emotional & Financial Cost of NICU Stays
23:09 Why Some Women Face Higher Risk
24:39 How Pregnant Women Can Access the Test
25:54 The Stats Every Expecting Mom Should Know
33:14 The Future of Preventive Maternal Care
36:17 What To Do If You Live in a Rural Area
Key Takeaways